Asia and Revu Baby Nalanda 2025. A new stability indicating UPLC-MS/MS methods for the simultaneous estimation of Abacavir, Dolutegravir and Lamivudine in pharmaceutical dosage forms. The Bioscan. 20, 4 (Dec. 2025), 788–806.